Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A loss-of-function IFNAR1 allele in Polynesia underlies severe viral diseases in homozygotes.
Bastard P, Hsiao KC, Zhang Q, Choin J, Best E, Chen J, Gervais A, Bizien L, Materna M, Harmant C, Roux M, Hawley NL, Weeks DE, McGarvey ST, Sandoval K, Barberena-Jonas C, Quinto-Cortés CD, Hagelberg E, Mentzer AJ, Robson K, Coulibaly B, Seeleuthner Y, Bigio B, Li Z, Uzé G, Pellegrini S, Lorenzo L, Sbihi Z, Latour S, Besnard M, Adam de Beaumais T, Jacqz Aigrain E, Béziat V, Deka R, Esera Tulifau L, Viali S, Reupena MS, Naseri T, McNaughton P, Sarkozy V, Peake J, Blincoe A, Primhak S, Stables S, Gibson K, Woon ST, Drake KM, Hill AVS, Chan CY, King R, Ameratunga R, Teiti I, Aubry M, Cao-Lormeau VM, Tangye SG, Zhang SY, Jouanguy E, Gray P, Abel L, Moreno-Estrada A, Minster RL, Quintana-Murci L, Wood AC, Casanova JL. Bastard P, et al. Among authors: hsiao kc. J Exp Med. 2022 Jun 6;219(6):e20220028. doi: 10.1084/jem.20220028. Epub 2022 Apr 20. J Exp Med. 2022. PMID: 35442418 Free PMC article.
Evaluation of Severe Combined Immunodeficiency and Combined Immunodeficiency Pediatric Patients on the Basis of Cellular Radiosensitivity.
Lobachevsky P, Woodbine L, Hsiao KC, Choo S, Fraser C, Gray P, Smith J, Best N, Munforte L, Korneeva E, Martin RF, Jeggo PA, Martin OA. Lobachevsky P, et al. Among authors: hsiao kc. J Mol Diagn. 2015 Sep;17(5):560-75. doi: 10.1016/j.jmoldx.2015.05.004. Epub 2015 Jul 4. J Mol Diagn. 2015. PMID: 26151233 Free PMC article.
Probiotic peanut oral immunotherapy is associated with long-term persistence of 8-week sustained unresponsiveness and long-lasting quality-of-life improvement.
Loke P, Hsiao KC, Lozinsky AC, Ashley SE, Lloyd M, Pitkin S, Axelrad CJ, Jayawardana KS, Tey D, Su EL, Robinson M, Leung ASY, Dunn Galvin A, Tang MLK. Loke P, et al. Among authors: hsiao kc. Clin Exp Allergy. 2022 Jun;52(6):806-811. doi: 10.1111/cea.14137. Epub 2022 May 10. Clin Exp Allergy. 2022. PMID: 35485166 No abstract available.
Probiotics and oral immunotherapy for peanut allergy - Authors' reply.
Tang MLK, Hsiao KC, Ponsonby AL, Donath S, Orsini F, Axelrad C, Pitkin S. Tang MLK, et al. Among authors: hsiao kc. Lancet Child Adolesc Health. 2017 Nov;1(3):e1-e2. doi: 10.1016/S2352-4642(17)30101-3. Epub 2017 Oct 10. Lancet Child Adolesc Health. 2017. PMID: 30169172 No abstract available.
Study protocol of a multicentre, randomised, controlled trial evaluating the effectiveness of probiotic and peanut oral immunotherapy (PPOIT) in inducing desensitisation or tolerance in children with peanut allergy compared with oral immunotherapy (OIT) alone and with placebo (the PPOIT-003 study).
Chebar Lozinsky A, Loke P, Orsini F, O'Sullivan M, L Prescott S, Gold MS, Quinn P, DunnGalvin A, Lk Tang M; PPOIT study team. Chebar Lozinsky A, et al. BMJ Open. 2020 Sep 9;10(9):e035871. doi: 10.1136/bmjopen-2019-035871. BMJ Open. 2020. PMID: 32912942 Free PMC article.
72 results